Suchergebnisse - "Riveiro-Barciela, Mar"

PubPharm (168)

1

Management of chronic HBV-HDV patients chronic HBV-HDV infection : A review on new management options

enthalten in: United European gastroenterology journal | 2024

von Buti, M. | Gonzalez, A. | Riveiro-Barciela, M. | +1

2

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors : Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

enthalten in: Gastroenterologia y hepatologia | 2024

von Riveiro-Barciela, M. | Carballal, S. | Díaz-González, �. | +12

3

Assessing the rate of non-linkage to care and identifying barriers in individuals living with hepatitis B. Results of the LINK-B study

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Feliu-Prius, A. | Barreira-Díaz, A. | Rando, A. | +8

4

An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Riveiro-Barciela, M. | Barreira-Díaz, A. | Salcedo, M. | +16

5

Editorial : Liver elastography for chronic hepatitis D-the end of liver biopsy?

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Buti, M. | Palom, A. | Riveiro-Barciela, M.

6

Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization : A nationwide study

enthalten in: Annals of hepatology | 2024

von Barreira-Díaz, A. | Riveiro-Barciela, M. | Fernández-Bonilla, E. | +16

7

Management of liver and gastrointestinal toxicity induced by immune checkpoint inhibitors : Position statement of the AEEH-AEG-SEPD-SEOM-GETECCU

enthalten in: Revista espanola de enfermedades digestivas | 2024

von Riveiro-Barciela, M. | Carballal, S. | Díaz-González, �. | +12

8

Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis : results from the HEBEM study

enthalten in: Journal of neurology | 2024

von Marzo, B. | Vidal-Jordana, A. | Castilló, J. | +6

9

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

enthalten in: Frontiers in immunology | 10 January 2024

von Kocheise, L. | Piseddu, I. | Vonderlin, J. | +22

10

Editorial : Liver elastography for chronic hepatitis D—the end of liver biopsy?

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Buti, M. | Palom, A. | Riveiro‐Barciela, M.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[17]